Question

Which of the following is NOT TRUE regarding intraosseous access?

A) Intraosseous access site can be used for blood samples for the laboratory tests and cross match.
B) Contraindications include fractured bones, bones with osteomyelitis, proximal bone fracture, previous sternotomy, and some rare disorders of bone development.
C) All of the IV mediation and blood products can be administered through the intraosseous access, and the onset of action and peak drug level are comparable to those of IV administration.
D) The intraosseous needle can be maintained more than 24 hours without increasing the risk of complications.
E) All of the above are TRUE statement.

Answer 1

The statement that the intraosseous needle can be maintained more than 24 hours without increasing the risk of complications is NOT TRUE. Intraosseous access is typically for short-term use due to the risk of complications after prolonged use.

Step-by-step explanation:

The statement that is NOT TRUE regarding intraosseous access is option D) The intraosseous needle can be maintained more than 24 hours without increasing the risk of complications. It is generally recommended that intraosseous access should be used for a short term, around 24 hours or less, due to the risk of complications such as infection or compartment syndrome after prolonged use.

Intraosseous access can indeed be used for drawing blood samples for laboratory tests and cross-matching (statement A), and it does have several contraindications including fractured bones and previous sternotomy (statement B). It is also true that medications and blood products can be administered through intraosseous access with onset and peak drug levels comparable to intravenous administration (statement C).